MetLifes Revenue Surges, Yet the Stock Declines

MetLife (MET) reported fiscal 2026 Q2 earnings on August 5, 2026, delivering revenue growth and a new $3 billion share repurchase program. The insurer exceeded expectations on adjusted EPS while announcing strategic capital deployment and operational progress under its New Frontier framework.

Revenue

MetLife’s total revenue surged 10.5% year-over-year to $19.15 billion, driven by robust performance across core segments. Premiums accounted for the largest share at $11.44 billion, while universal life and investment-type product policy fees contributed $1.37 billion. Net investment income added $6.70 billion, and other revenues totaled $845 million. However, the company faced headwinds from net investment losses ($428 million) and net derivative losses ($772 million), which partially offset top-line gains.

Earnings/Net Income

The company’s earnings per share (EPS) rose 4.7% to $1.10, reflecting disciplined cost management and volume growth. Net income climbed 6.0% to $779 million, underscoring improved profitability. The EPS growth aligns with the company’s strategic execution and operational resilience.

Price Action

Following the earnings report, MET’s stock declined 0.25% on the latest trading day and 0.78% for the week. However, it gained 6.41% month-to-date, suggesting mixed investor sentiment amid strong fundamentals.

Post-Earnings Price Action Review

Despite a modest 0.25% decline in the latest trading day, the stock’s 6.41% monthly gain indicates underlying confidence. A backtest of a hypothetical “buy after revenue report” strategy showed mixed results: a 1.1% gain over 30 trading days but a 1.4% loss over 30 calendar days. The test, based on the March 31, 2026, quarter ($19.07 billion revenue), highlights the challenge of timing entry points. Notably, MetLife’s revenue has consistently increased in recent quarters, complicating the evaluation of a “revenue equal” strategy. While the single-window test was mildly positive, the limited sample size and timing proxy suggest further analysis is needed.

CEO Commentary

CEO Michel Khalaf praised the quarter’s 20% rise in adjusted EPS, attributing success to strong underwriting and volume growth. He emphasized the New Frontier strategy’s effectiveness, noting a 17% adjusted return on equity for two consecutive quarters. Khalaf highlighted MetLife’s ability to create value across economic cycles, leveraging scale, diversification, and financial strength.

Guidance

Management did not provide specific numerical guidance but affirmed confidence in operational metrics. The direct expense ratio is on track to meet annual targets, and adjusted return on equity is expected to remain at the top of its range. Risks include interest rate volatility, credit spreads, and regulatory shifts, with no guarantees on future performance.

Additional News

MetLife announced a $3 billion share repurchase program, expanding its capital return commitment. This follows a $400 million authorization in April 2025, reflecting confidence in long-term value creation. Separately, the company’s private equity fund secured $1.2 billion in commitments, underscoring its strategic diversification. CEO Michel Khalaf reiterated the New Frontier strategy’s success, citing disciplined execution and balanced growth.